Titel	Veröffentlichungsdatum	Sprache	Zitate
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines	2003/07/01	English	552
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden	2006/05/01	English	535
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies	2011/02/01	English	350
Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus	2000/10/01	English	337
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies	2000/11/01	English	329
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus	2006/09/01	English	290
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity	2004/09/01	English	259
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients	2007/11/27	English	257
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)	2008/04/01	English	256
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis	2002/03/01	English	252
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study	2001/06/01	English	248
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies	2013/10/01	English	241
Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort	1999/03/01	English	229
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases	2009/07/03	English	217
The innate immune system in SLE: type I interferons and dendritic cells	2008/05/01	English	213
Cardiac involvement in systemic lupus erythematosus	2005/09/01	English	205
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus	2001/02/01	English	203
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE	2012/12/21	English	203
Rationale for interleukin-6 blockade in systemic lupus erythematosus	2004/05/01	English	202
Classification and definition of major flares in SLE clinical trials	1999/10/01	English	198
Validation of a systemic lupus activity questionnaire (SLAQ) for population studies	2003/04/01	English	198
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis	2016/01/24	English	197
A review of health related quality of life in systemic lupus erythematosus	2006/10/01	English	197
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies	1997/07/01	English	194
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus	1998/02/01	English	185
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity	1995/10/01	English	180
A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection	1992/02/01	English	178
Adjuvants and autoimmunity	2009/10/30	English	174
Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus	2001/07/01	English	165
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis	1997/06/01	English	164